immune response observed might not be the sole factor in the progression of the disease, but it does illustrate a crucial aspect of MSA’s pathology that differentiates it from Parkinson’s disease.
This research could lead to a reevaluation of therapeutic strategies aimed at modulating the immune response in MSA patients. Given the current lack of treatment options, understanding the unique immune profile of MSA could provide insights into potential interventions that could mitigate its rapid progression. Future studies will be essential to explore these dynamics further and to clarify the role of microglia in neurodegeneration.